SCHEMBL1011073

SCHEMBL1011073

COc1cccc(Cn2cc[n+](C)c2)c1

nearest known ligand 0.56

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LPO P22079 3/20 0.56
CMA1 P23946 1/20 0.51
SIGMAR1 Q99720 2/20 0.49
LMNA P02545 1/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
TAAR1 Q96RJ0 3/20 0.44
IDO1 P14902 2/20 0.44
AGXT P21549 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2194865 0.99 LPO (0.55) LPOCMA1SIGMAR1LMNATP53
Hydrochloric Acid SCHEMBL2011318 0.99 LPO (0.55) LPOCMA1SIGMAR1LMNATP53
SCHEMBL1009269 0.81 MAPT (0.46) CMA1SIGMAR1LMNATP53MAPT
Bromide SCHEMBL2196188 0.80 MAPT (0.45) CMA1SIGMAR1LMNAMAPTKDM4E
SCHEMBL20138573 0.80 CYP11B1 (0.53) TP53MAPTKDM4EALDH1A1TAAR1
SCHEMBL27696269 0.79 LPO (0.68) LPOCMA1SIGMAR1LMNATP53
Hydrochloric Acid SCHEMBL2012582 0.79 CYP11B1 (0.55) TP53MAPTKDM4EALDH1A1TAAR1
SCHEMBL1009623 0.78 HSP90AA1 (0.49) SIGMAR1LMNAKDM4EALDH1A1KMT2A
SCHEMBL667065 0.77 PON1 (0.50) CMA1SIGMAR1LMNATP53MAPT
Bromide SCHEMBL2194611 0.77 HSP90AA1 (0.48) SIGMAR1LMNAKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268652-A2 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2011-01-05 EP disclosed
WO-2009118475-A2 PLATINUM-N-HETEROCYCLIC CARBENE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2009-10-01 WO disclosed